Skip to main content
. 2006 Sep;2(3):261–267. doi: 10.2147/nedt.2006.2.3.261

Figure 1.

Figure 1

Changes from baseline in migraine period frequency during controlled clinical trials (Brandes et al 2004; Diener et al 2004; Silberstein et al 2004): pooled data from patients receiving topiramate (TPM) 100 mg/day (Bussone et al 2005).

*p < 0.05; **p < 0.01; ***p < 0.001.